Pharmacy benefit managers defended their roles in a Congressional hearing amid accusations of promoting expensive treatments. Executives claimed their models save money, while a report highlighted anti-competitive practices and high drug prices.
US pharmaceutical industry intermediaries defend their role
Original Article by Amina Niasse & Bhanvi Satija | Reuters | 23 July 2024
Pharmacy benefit managers defended their roles in a Congressional hearing amid accusations of promoting expensive treatments. Executives claimed their models save money, while a report highlighted anti-competitive practices and high drug prices.
More Posts
Compounded semaglutide appeal dismissed
A court has upheld restrictions on compounded semaglutide at iDexis while regulatory investigations continue.
Read more...
WHO’s Africa Chief Urges Action, Not Talk, on Primary Healthcare
WHO Africa director Mohamed Janabi urged governments to finance primary healthcare and pursue health sovereignty.
Read more...
Unpaid specialist training strains SA doctors
Unpaid specialist training is growing in South Africa as scarce funded posts leave doctors working without salaries.
Read more...